Selank

Selank influences the way the body responds to stress and helps support calmer and more stable behavior without acting as a strong "sedative".

As a molecular class it is regarded as a synthetic heptapeptide associated with neuropeptide signaling and with modulation of *GABAergic* and serotonergic pathways, described in the scientific literature as an anxiolytic nootropic agent for experimental models (general review: Wikipedia: Selank; review publications and PubMed entries: PubMed search).

Mechanism of action 

Data suggest that Selank may influence the expression of genes and mediators associated with anxiety and stress-response, as well as modulate neurotransmitter systems (GABA/serotonin) and neuroinflammatory signals in preclinical contexts. The most important conceptual focus in experiment design is neuromodulation through multicomponent pathways, rather than a single receptor target. In practice this means planning panels of endpoints (behavioral tests, transcriptomics/ELISA, markers of neuroinflammation), instead of a single biomarker.

Use in laboratory and clinical settings

In the laboratory Selank is used for models of stress/anxiety, neuroimmune interactions and behavioral pharmacology; in the clinical setting outside regulatory approval (there is no FDA/EMA monograph for a medicinal product) use should be considered only as a scientific hypothesis, not an established therapy (regulatory context: FDA, EMA).

Pharmacokinetics

As a peptide, Selank is subject to proteolytic degradation; in experimental design plan for matrix stability, time series and vehicle/buffer controls, as well as analytical confirmation (HPLC/LC-MS) of identity and degradation products.

Purity and formula

Selank from MyPeptid provides conditions for reproducible testing, as it has purity over 99%, suitable for analytical and functional studies. 

Chemical formula: C33H57N11O9

The product is sold for educational and research purposes only, not for human use.